Enhanced anti-cancer and antimicrobial activities of curcumin nanoparticles

References

• Aggarwal BB, Harikumar KB. 2009. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol. 41:40–59.
   PubMed Web of Science ®Google Scholar
• Aggarwal BB, Kumar A, Bharti AC. 2003. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. 23:363–398.
   PubMed Web of Science ®Google Scholar
• Aggarwal BB, Sung B. 2009. Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol Sci. 30:85–94.
   PubMed Web of Science ®Google Scholar
• Akram M, Shahab-Uddin AA, Usmanghani K, Hannan A, Mohiuddin E, Asif M. 2010. Curcuma longa and curcumin: a review article. Rom J Biol-Plant Biol. 55:65–70.
   Google Scholar
• Almaaytah A, Tarazi S, Abu-Alhaijaa A, Altall Y, Alshar’i N, Bodoor K, Al-Balas Q. 2014. Enhanced antimicrobial activity of AamAP1-lysine, a novel synthetic peptide analog derived from the scorpion venom peptide AamAP1. Pharmaceuticals. 7:502–516.
   Google Scholar
• Almaaytah A, Tarazi S, Mhaidat N, Al-Balas Q, Mukattash TL. 2013. Mauriporin, a novel cationic α-helical peptide with selective cytotoxic activity against prostate cancer cell lines from the venom of the scorpion Androctonus mauritanicus. Int J Pept Res Ther. 19:281–293.
   Web of Science ®Google Scholar
• Ammon H, Wahl MA. 1991. Pharmacology of Curcuma longa. Planta Med. 57:1–7.
   PubMed Web of Science ®Google Scholar
• Banerjee A, Kunwar A, Mishra B, Priyadarsini K. 2008. Concentration dependent antioxidant/pro-oxidant activity of curcumin: studies from AAPH induced hemolysis of RBCs. Chem Biol Interac. 174:134–139.
   PubMed Web of Science ®Google Scholar
• Basnet P, Skalko-Basnet N. 2011. Curcumin: an anti-inflammatory molecule from a curry spice on the path to cancer treatment. Molecules. 16:4567–4598.
   PubMed Web of Science ®Google Scholar
• Basniwal RK, Buttar HS, Jain V, Jain N. 2011. Curcumin nanoparticles: preparation, characterization, and antimicrobial study. J Agric Food Chem. 59:2056–2061.
   PubMed Web of Science ®Google Scholar
• Basri DF, Luoi CK, Azmi AM, Latip J. 2012. Evaluation of the combined effects of stilbenoid from Shorea gibbosa and vancomycin against methicillin-resistant Staphylococcus aureus (MRSA). Pharmaceuticals. 5:1032–1043.
   Google Scholar
• Bass S, Young AL. 1996. Dietary Supplement Health and Education Act. A Legislative History and Analysis. Washington (DC): The Food and Drug Law Institute.
   Google Scholar
• Bisht S, Feldmann G, Soni S, Ravi R, Karikar C, Maitra A, Maitra A. 2007. Polymeric nanoparticle-encapsulated curcumin (“nanocurcumin”): a novel strategy for human cancer therapy. J Nanobiotechnol. 5:1–18.
   PubMedGoogle Scholar
• Capasso A, de Feo V, de Simone F, Sorrentino L. 1996. Pharmacological effects of aqueous extract from Valeriana adscendens. Phytother Res. 10:309–312.
   Web of Science ®Google Scholar
• Dhillon N, Aggarwal BB, Newman RA, Wolff RA, Kunnumakkara AB, Abbruzzese JL, et al. 2008. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res. 14:4491–4499.
   PubMed Web of Science ®Google Scholar
• Duvoix A, Blasius R, Delhalle S, Schnekenburger M, Morceau F, Henry E, Dicato M, Diederich M. 2005. Chemopreventive and therapeutic effects of curcumin. Cancer Lett. 223:181–190.
   PubMed Web of Science ®Google Scholar
• Feng SS. 2004. Nanoparticles of biodegradable polymers for new-concept chemotherapy. Expert Rev Med Devices. 1:115–125.
   PubMed Web of Science ®Google Scholar
• Gupta SC, Patchva S, Aggarwal BB. 2013. Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J. 15:195–218.
   PubMed Web of Science ®Google Scholar
• Gupta SC, Patchva S, Koh W, Aggarwal BB. 2012. Discovery of curcumin, a component of golden spice, and its miraculous biological activities. Clin Exp Pharmacol Physiol. 39:283–299.
   PubMed Web of Science ®Google Scholar
• Hamed OA, Mehdawi N, Taha AA, Hamed EM, Al-Nuri MA, Hussein AS. 2013. Synthesis and antibacterial activity of novel curcumin derivatives containing heterocyclic moiety. Iran J Pharm Res. 12:47–56.
   Web of Science ®Google Scholar
• Jain J, Arora S, Rajwade JM, Omray P, Khandelwal S, Paknikar KM. 2009. Silver nanoparticles in therapeutics: development of an antimicrobial gel formulation for topical use. Mol Pharm. 6:1388–1401.
   PubMed Web of Science ®Google Scholar
• Jonas WB. 1998. Alternative medicine—learning from the past, examining the present, advancing to the future. JAMA. 280:1616–1618.
   PubMed Web of Science ®Google Scholar
• Kanai M, Yoshimura K, Asada M, Imaizumi A, Suzuki C, Matsumoto S, et al. 2011. A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer. Cancer Chemother Pharmacol. 68:157–164.
   PubMed Web of Science ®Google Scholar
• Komatsuzawa H, Ohta K, Sugai M, Fujiwara T, Glanzmann P, Berger-Bächi B, Suginaka H. 2000. Tn551-mediated insertional inactivation of the fmtB gene encoding a cell wall-associated protein abolishes methicillin resistance in Staphylococcus aureus. J Antimicrob Chemother. 45:421–431.
   PubMed Web of Science ®Google Scholar
• Kunchandy E, Rao M. 1989. Effect of curcumin on hydroxyl radical generation through Fenton reaction. Int J Pharm. 57:173–176.
   Web of Science ®Google Scholar
• Liu D. 2013. Engineering Nano-curcumin with Enhanced Solubility and In-vitro Anti-cancer Bioactivity. New Brunswick, NJ: Rutgers University–Graduate School.
   Google Scholar
• Miller LG. 1998. Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions. Arch Int Med. 158:2200–2211.
   PubMed Web of Science ®Google Scholar
• Mukerjee A, Vishwanatha JK. 2009. Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy. Anticancer Res. 29:3867–3875.
   PubMed Web of Science ®Google Scholar
• Muqbil I, Masood A, Sarkar FH, Mohammad RM, Azmi AS. 2011. Progress in nanotechnology based approaches to enhance the potential of chemopreventive agents. Cancers. 3:428–445.
   PubMedGoogle Scholar
• Nakamura K, Yasunaga Y, Segawa T, Ko D, Moul JW, Srivastava S, Rhim JS. 2002. Curcumin down-regulates AR gene expression and activation in prostate cancer cell lines. Int J Oncol. 21:825–830.
   PubMed Web of Science ®Google Scholar
• Niki E, Komuro E, Takahashi M, Urano S, Ito E, Terao K. 1988. Oxidative hemolysis of erythrocytes and its inhibition by free radical scavengers. J Biol Chem. 263:19809–19814.
   PubMed Web of Science ®Google Scholar
• Rao M. 1993. Curcumin inhibits iron-dependent lipid peroxidation. Int J Pharm. 100:93–97.
   Web of Science ®Google Scholar
• Sa G, Das T. 2008. Anti cancer effects of curcumin: cycle of life and death. Cell Div. 3:14
   PubMed Web of Science ®Google Scholar
• Schraufstätter E, Bernt H. 1949. Antibacterial action of curcumin and related compounds. Nature. 164:456–457.
   PubMed Web of Science ®Google Scholar
• Sharma RA, Steward WP, Gescher AJ. 2007. Pharmacokinetics and Pharmacodynamics of Curcumin. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease. New York: Springer, pp. 453–470.
   Google Scholar
• Shishodia S, Chaturvedi MM, Aggarwal BB. 2007. Role of curcumin in cancer therapy. Curr Prob Cancer. 31:243–305.
   PubMed Web of Science ®Google Scholar
• Sou K. 2012. Curcumin towards nanomedicine. Recent Pat Nanomed. 2:133–145.
   Google Scholar
• Tønnesen HH, Greenhill JV. 1992. Studies on curcumin and curcuminoids. XXII: curcumin as a reducing agent and as a radical scavenger. Int J Pharm. 87:79–87.
   Web of Science ®Google Scholar
• Tønnesen HH, Kristensen S, Grinberg LN. 1994. Studies on curcumin and curcuminoids: XXV. Inhibition of primaquine-induced lysis of human red blood cells by curcumin. Int J Pharm. 110:161–167.
   Web of Science ®Google Scholar
• Vogel A, Pelletier J. 1815. Examen chimique de la racine de Curcuma. J Pharm. 1:289–300.
   Google Scholar
• Yallapu MM, Dobberpuhl MR, Maher DM, Jaggi M, Chauhan SC. 2012. Design of curcumin loaded cellulose nanoparticles for prostate cancer. Curr Drug Metab. 13:120–128.
   PubMed Web of Science ®Google Scholar
• Yallapu MM, Ebeling MC, Chauhan N, Jaggi M, Chauhan SC. 2011. Interaction of curcumin nanoformulations with human plasma proteins and erythrocytes. Int J Nanomed. 6:2779–2790.
   PubMed Web of Science ®Google Scholar
• Yusra M, Duaa SS, Dalal AA. 2013. Novel probiotic bifidobacterium overcomes synergistic effect of three natural biotic omni drug and antibiotic against some UTI pathogens. Int J Sci Nature. 4:456–462.
   Google Scholar